UiPath Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell

33

PATH
UiPath

Last Price:

11.96

Seasonality Move:

-16.37%

Sell

38

RARE
Ultragenyx Pharmaceutical

Last Price:

39.58

Seasonality Move:

3.65%

Sell

33

UiPath (PATH) is a Sell

Is UiPath a Buy, Sell or Hold?

The current UiPath [PATH] share price is $11.37. The Score for PATH is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

38

Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PATH Stock Price Chart

What is UiPath's stock price today?

The UiPath share price today is $11.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PATH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

PATH Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.99	Sell
Relative Strength Index (14 RSI):	18.57	Sell
Chaikin Money Flow:	9373337	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11.05 - 18.79)	Sell
Bollinger Bands (100):	(16.26 - 24.46)	Sell

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.74	Sell
Relative Strength Index (14 RSI):	40.05	Sell
Chaikin Money Flow:	76134	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(39.06 - 42.34)	Sell
Bollinger Bands (100):	(41.13 - 48.85)	Sell

PATH Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	11.6	Sell
20-day SMA:	13.58	Sell
50-day SMA:	17.29	Sell
200-day SMA:	20	Sell
8-day EMA:	11.72	Sell
20-day EMA:	13.44	Sell
50-day EMA:	16.49	Sell
200-day EMA:	19.18	Sell

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	40.68	Sell
20-day SMA:	40.48	Sell
50-day SMA:	42.18	Sell
200-day SMA:	42.45	Sell
8-day EMA:	39.81	Sell
20-day EMA:	40.64	Sell
50-day EMA:	42.13	Sell
200-day EMA:	43.5	Sell

UiPath Earnings Growth & PATH Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.41 per share, and a decrease next year of $0.10 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

UiPath Technical Analysis

	Jun 6	Jun 7	Jun 10	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20
	Jun
	06	07	10	11	12	13	14	17	18	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

	Jun 6	Jun 7	Jun 10	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20
	Jun
	06	07	10	11	12	13	14	17	18	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):